Klemen Dovc1, Kevin Cargnelutti2, Anze Sturm3, Julij Selb4, Natasa Bratina5, Tadej Battelino6. 1. Department of Pediatric Endocrinology, Diabetes and Metabolic Diseases, University Children's Hospital, University Medical Centre, Ljubljana, Slovenia; Wellcome Trust-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, UK. 2. Faculty of Medicine and Surgery, University of Udine, Udine, Italy. 3. Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia. 4. University Clinic of Respiratory and Allergic Diseases Golnik, Kranj, Slovenia. 5. Department of Pediatric Endocrinology, Diabetes and Metabolic Diseases, University Children's Hospital, University Medical Centre, Ljubljana, Slovenia. 6. Department of Pediatric Endocrinology, Diabetes and Metabolic Diseases, University Children's Hospital, University Medical Centre, Ljubljana, Slovenia; Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia. Electronic address: tadej.battelino@mf.uni-lj.si.
Abstract
AIMS: The objective of this nationwide population-based cohort study was to evaluate the correlation between continuous glucose monitoring (CGM) use and glucose variability in pre-schoolers with type 1 diabetes. METHODS: We analysed data from the Slovenian National Registry. The primary endpoint was the difference in glucose variability between periods, during which participants were using CGM and periods, during which CGM was not used, over 5 years. RESULTS: A total of 40 children <8 years old were followed for an estimated observational period of 116 patient/years. Mean age at CGM initiation was 3.5 (±1.7) years. Both standard deviation of mean glucose [3.6 mmol/L (3.2-3.9) with CGM and 4.3 mmol/L (3.8-4.7) without CGM, p < 0.001] and coefficient of variation [44.0% (40.4-47.0) with CGM and 46.1% (42.3-49.4) without CGM, p = 0.021] were lower during the periods, when CGM was used. Frequent CGM use (>5 days/week) was associated with a 0.4% [4.4 mmol/mol] reduction in glycated haemoglobin level (7.6% compared to 7.2%, p = 0.047). CONCLUSIONS: Our results indicate that the use of CGM was associated with reduced glucose variability during a 5 year follow-up period among pre-schoolers with type 1 diabetes. TRIAL REGISTRATION: Clinicaltrials.gov: NCT-03293082.
AIMS: The objective of this nationwide population-based cohort study was to evaluate the correlation between continuous glucose monitoring (CGM) use and glucose variability in pre-schoolers with type 1 diabetes. METHODS: We analysed data from the Slovenian National Registry. The primary endpoint was the difference in glucose variability between periods, during which participants were using CGM and periods, during which CGM was not used, over 5 years. RESULTS: A total of 40 children <8 years old were followed for an estimated observational period of 116 patient/years. Mean age at CGM initiation was 3.5 (±1.7) years. Both standard deviation of mean glucose [3.6 mmol/L (3.2-3.9) with CGM and 4.3 mmol/L (3.8-4.7) without CGM, p < 0.001] and coefficient of variation [44.0% (40.4-47.0) with CGM and 46.1% (42.3-49.4) without CGM, p = 0.021] were lower during the periods, when CGM was used. Frequent CGM use (>5 days/week) was associated with a 0.4% [4.4 mmol/mol] reduction in glycated haemoglobin level (7.6% compared to 7.2%, p = 0.047). CONCLUSIONS: Our results indicate that the use of CGM was associated with reduced glucose variability during a 5 year follow-up period among pre-schoolers with type 1 diabetes. TRIAL REGISTRATION: Clinicaltrials.gov: NCT-03293082.
Authors: Christine A March; Michelle Nanni; Traci M Kazmerski; Linda M Siminerio; Elizabeth Miller; Ingrid M Libman Journal: Pediatr Diabetes Date: 2020-04-22 Impact factor: 4.866
Authors: Benjamin Udoka Nwosu; Shamima Yeasmin; Sanaa Ayyoub; Shwetha Rupendu; Tony R Villalobos-Ortiz; Gabrielle Jasmin; Sadichchha Parajuli; Bita Zahedi; Emily Zitek-Morrison; Laura C Alonso; Bruce A Barton Journal: J Pediatr Endocrinol Metab Date: 2020-07-28 Impact factor: 1.520
Authors: Kylie Karnebeek; Jesse M Rijks; Elke Dorenbos; Willem-Jan M Gerver; Jogchum Plat; Anita C E Vreugdenhil Journal: Nutrients Date: 2020-04-26 Impact factor: 5.717
Authors: Tadej Battelino; Thomas Danne; Richard M Bergenstal; Stephanie A Amiel; Roy Beck; Torben Biester; Emanuele Bosi; Bruce A Buckingham; William T Cefalu; Kelly L Close; Claudio Cobelli; Eyal Dassau; J Hans DeVries; Kim C Donaghue; Klemen Dovc; Francis J Doyle; Satish Garg; George Grunberger; Simon Heller; Lutz Heinemann; Irl B Hirsch; Roman Hovorka; Weiping Jia; Olga Kordonouri; Boris Kovatchev; Aaron Kowalski; Lori Laffel; Brian Levine; Alexander Mayorov; Chantal Mathieu; Helen R Murphy; Revital Nimri; Kirsten Nørgaard; Christopher G Parkin; Eric Renard; David Rodbard; Banshi Saboo; Desmond Schatz; Keaton Stoner; Tatsuiko Urakami; Stuart A Weinzimer; Moshe Phillip Journal: Diabetes Care Date: 2019-06-08 Impact factor: 19.112
Authors: Nunzio Camerlingo; Martina Vettoretti; Andrea Facchinetti; Giovanni Sparacino; Julia K Mader; Pratik Choudhary; Simone Del Favero Journal: Sci Rep Date: 2020-10-23 Impact factor: 4.379